These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
800 related items for PubMed ID: 16889577
1. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH, Russ GR, Coates PT. Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577 [Abstract] [Full Text] [Related]
2. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Taylor AL, Marcus R, Bradley JA. Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320 [Abstract] [Full Text] [Related]
3. Posttransplant lymphoproliferative disorder. Everly MJ, Bloom RD, Tsai DE, Trofe J. Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127 [Abstract] [Full Text] [Related]
4. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients. Preiksaitis JK. Clin Infect Dis; 2004 Oct 01; 39(7):1016-23. PubMed ID: 15472855 [Abstract] [Full Text] [Related]
5. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Styczynski J, Einsele H, Gil L, Ljungman P. Transpl Infect Dis; 2009 Oct 01; 11(5):383-92. PubMed ID: 19558376 [Abstract] [Full Text] [Related]
7. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M. Haematologica; 2006 Aug 01; 91(8):1059-67. PubMed ID: 16885046 [Abstract] [Full Text] [Related]
8. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Transpl Int; 2007 Mar 01; 20(3):207-18. PubMed ID: 17291214 [Abstract] [Full Text] [Related]
10. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K. Scand J Infect Dis; 2007 Feb 01; 39(3):235-44. PubMed ID: 17366054 [Abstract] [Full Text] [Related]
11. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A. Bone Marrow Transplant; 2006 Mar 01; 37(6):539-46. PubMed ID: 16462755 [Abstract] [Full Text] [Related]
12. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F. Pediatr Transplant; 2009 Feb 01; 13(1):54-62. PubMed ID: 18518912 [Abstract] [Full Text] [Related]
14. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438 [Abstract] [Full Text] [Related]
15. Treatment for Epstein-Barr virus-associated PTLD. Gross TG. Herpes; 2009 Jan 10; 15(3):64-7. PubMed ID: 19306606 [Abstract] [Full Text] [Related]
16. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients. Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C. New Microbiol; 2006 Oct 10; 29(4):231-41. PubMed ID: 17201089 [Abstract] [Full Text] [Related]
17. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA. Clin Transplant; 2006 Oct 10; 20(3):389-93. PubMed ID: 16824159 [Abstract] [Full Text] [Related]
18. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C, Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Br J Haematol; 2010 Jun 10; 149(5):675-92. PubMed ID: 20408847 [Abstract] [Full Text] [Related]
19. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P. J Heart Lung Transplant; 2008 Jan 10; 27(1):100-5. PubMed ID: 18187094 [Abstract] [Full Text] [Related]